Publications by authors named "G Annechini"

Claim this Profile
P
Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro-HL multicenter study.
Giovanni Manfredi Assanto, Eleonora Alma, Alessandro Cellini, Giovanni Marsili, Gianluca Maiorana, Giorgia Annechini

Hemasphere· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD.
S Sorella, G M Assanto, Gianna Maria D'Elia, Giorgia Annechini, Matteo Totaro

Leuk Lymphoma· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial.
Alessandro Pulsoni, Simone Ferrero, Maria Elena Tosti, Stefano Luminari, Alessandra Dondi, Giorgia Annechini

Lancet Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early clearance of hairy cell leukaemia in the bone marrow after first-line treatment with cladribine predicts a favourable outcome.
S Ligia, M Passucci, G M Assanto, G M D'Elia, G Annechini

Br J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study.
Giovanni Manfredi Assanto, Matteo Totaro, Rebecca Poggiali, Adele Delli Paoli, Giorgia Annechini

Mediterr J Hematol Infect Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis